XML 48 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Business Acquisition (Narrative) (Details)
$ in Thousands, € in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 30, 2014
USD ($)
Apr. 30, 2014
EUR (€)
Aug. 31, 2016
USD ($)
item
Mar. 31, 2016
USD ($)
item
Jan. 31, 2016
USD ($)
Mar. 31, 2017
Mar. 31, 2016
USD ($)
Dec. 31, 2016
USD ($)
Business Acquisition                
Payment to Acquire Business, Gross         $ 800   $ 4,761  
Useful life of intangibles           12 years   12 years
Deposit that ANP previously paid which was effectively eliminated upon the consummation of the transaction         900      
Goodwill related to acquisition of business               $ 391
International Medication Systems (UK) Limited                
Business Acquisition                
Marketing authorizations acquired     $ 9,200          
Manufacturing equipment acquired     100          
Deferred tax liability assumed     $ 1,600          
Number of Marketing Authorizations Acquired | item     33          
Number of Different Injectable Chemical Entities | item     11          
Payment to Acquire Business, Gross     $ 7,700          
Useful life of intangibles     10 years          
Hikma Pharmaceuticals PLC                
Business Acquisition                
Number of Injectable Products Acquired | item       14        
Number of Different Injectable Chemical Entities | item       11        
Payment to Acquire Business, Gross       $ 4,000        
Useful life of intangibles       15 years        
Assets acquired       $ 4,000     $ 4,000  
Merck Sharpe & Dohme's API                
Business Acquisition                
Purchase price $ 34,400 € 24.8            
Number Of Years Required To Transfer Starting Material           2 years    
Letop                
Business Acquisition                
Purchase price         1,700      
Assets acquired         1,400      
Liabilities assumed         $ 100